Ayala Pharmaceuticals Inc (ADXS)
0.55
+0.01
(+1.85%)
USD |
OTCM |
Apr 25, 16:00
Ayala Pharmaceuticals Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.243M |
| December 31, 2022 | 0.692M |
| September 30, 2022 | 1.733M |
| June 30, 2022 | 2.267M |
| March 31, 2022 | 2.99M |
| December 31, 2021 | 3.506M |
| September 30, 2021 | 3.364M |
| Date | Value |
|---|---|
| June 30, 2021 | 3.397M |
| March 31, 2021 | 3.681M |
| December 31, 2020 | 3.708M |
| September 30, 2020 | 3.076M |
| June 30, 2020 | 3.263M |
| March 31, 2020 | 3.07M |
| December 31, 2019 | 2.334M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.243M
Minimum
Jun 2023
3.708M
Maximum
Dec 2020
2.666M
Average
3.073M
Median
Revenue (TTM) Benchmarks
| Taro Pharmaceutical Industries Ltd | 610.83M |
| InspireMD Inc | 6.205M |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 0.357M |